Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13052013 | 0.92 | CCR5 (1.00) | CCR5KCNH2 | |
| SCHEMBL13052025 | 0.92 | CCR5 (0.90) | CCR5KCNH2 | |
| SCHEMBL13052012 | 0.91 | CCR5 (0.89) | CCR5KCNH2 | |
| SCHEMBL3752763 | 0.91 | CCR5 (0.89) | CCR5KCNH2 | |
| SCHEMBL3752758 | 0.91 | CCR5 (0.89) | CCR5KCNH2 | |
| SCHEMBL13052027 | 0.91 | CCR5 (0.89) | CCR5KCNH2 | |
| SCHEMBL3758405 | 0.91 | CCR5 (0.89) | CCR5KCNH2 | |
| SCHEMBL13052041 | 0.90 | CCR5 (0.86) | CCR5KCNH2 | |
| SCHEMBL13052053 | 0.90 | CCR5 (0.84) | CCR5KCNH2 | |
| SCHEMBL13052039 | 0.90 | CCR5 (0.84) | CCR5KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100298366-A1 | CHEMOKINE RECEPTOR BINDING COMPOUNDS | GENZYME CORPORATION (US) | 2010-11-25 | — | — | US | disclosed |
| US-7790747-B2 | Chemokine receptor binding compounds | GENZYME CORPORATION (US) | 2010-09-07 | — | — | US | disclosed |
| US-20090099205-A1 | Chemokine receptor binding compounds | GENZYME CORPORATION | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298366-A1 | CHEMOKINE RECEPTOR BINDING COMPOUNDS | CCR5, CXCR3, CCL5 | CCR5 1/4885KCNH2 4679/4885 |
| US-20090099205-A1 | Chemokine receptor binding compounds | CCR5, CXCR3, CCL5 | CCR5 1/4885KCNH2 4679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.